Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-03-15
2009-06-30
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S017000
Reexamination Certificate
active
07553841
ABSTRACT:
The present invention is directed to compounds of the formulas I and II: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R15, R16, R17, R18, R19, R25, R26, Y, Z, l, m, n and the broken lines are as defined herein which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.
REFERENCES:
patent: 6743794 (2004-06-01), Bonjouklian et al.
patent: WO01/22919 (2001-04-01), None
patent: WO 02/13824 (2002-02-01), None
patent: WO 2004/110376 (2004-12-01), None
Abbadie et al. “CCR-2 antagonists . . . ” CA 142:69197 (2004).
Sekiya et al. “Preparation of alpha imidazolobenzoyl . . . ” CA 119:203414 (1993).
Cohen et al. “Cytokine function” Am. J. Clin. path. v.105(5) p. 589-598 (1996).
Yang et al. “Disovery of 2-piperidinyl . . . ” J. Med. Chem. v.50, p. 2609-2611 (1997).
Jiao Richard
Yang Lihu
Chang Celia
Daniel Mark R.
McGinnis James L.
Merck & Co. , Inc.
LandOfFree
Amino cyclobutylamide modulators of chemokine receptor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino cyclobutylamide modulators of chemokine receptor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino cyclobutylamide modulators of chemokine receptor activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4102599